T-817
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T-817, covering 2017-11-24 to 2017-11-24. Get the full timeline:
Most recent: Clinical Trial Update: PK Study of T-817 in Subjects With Hepatic Impairment [Phase 1]